Therapeutic strategies in multiple myeloma.

In the past decade a number of single agents and combinations of drugs have been introduced in the treatment of patients with multiple myeloma. In this paper special attention is directed to the analysis of prognostic factors and the identification of subgroups at the time of diagnosis, stable plateau phase following induction and at the time of relapse. A comprehensive approach to the treatment of patients with multiple myeloma is presented.